How blockchain adds trust to pharmaceutical supply chains

APharmaceutical fraud remains a major challenge for the healthcare industry and the coronavirus pandemic has led to a further rise in counterfeit medicines creating a serious health threat to patients and significant challenges for enforcement authorities. From a supply chain perspective, it diminishes the commercial trust that needs to exist between organisations to provide essential products from manufacturing to patient. In the US alone, according to Deloitte, more than $200bn is lost each year because of counterfeit drugs infiltrating insecure supply chains.

Read our article on Pharmiweb.com